Conference Papers
Bridgewater JA; Gardini AC; Wilmink H; Mercade TM; Sim H-W; Verslype C; Roderburg C; Touchefeu Y; McDermott RS; Kordes M; Lee C-K; Vogel A; Kzhdryan HGK; Vidra RA; Rumpold H; Sullivan A; Gharbi H; Minguez VM; Rober R; Rimassa L, 2025, 'Preliminary efficacy outcomes of ivosidenib in patients with IDH1-mutated cholangiocarcinoma (mIDH1 CCA): Initial results from the phase IIIb ProvIDHe study', in ANNALS OF ONCOLOGY, ELSEVIER, SPAIN, Barcelona, presented at ESMO Gastrointestinal Cancers Congress, SPAIN, Barcelona, 02 July 2025 - 05 July 2025, http://dx.doi.org/10.1016/].annonc.2025.05.277
Price T; Sim H-W; Eastgate M; Mclachlan S-A; Dean A; George D; Weeratunge R; Zhang Y; Oo MM, 2025, 'Australian patients with IDH1 mutatedcholangiocarcinoma treated with ivosidenib: initial resultsfrom the phase 3b ProvIDHe study', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY
Thavaneswaran S; Koh E-S; Sim H-W; Ballinger ML; Thomas DM; Barnes EH; Kong B; O'callaghan C; Pitz M; Hawkins C; Roberge D; Pallimulla S; Ralston L; Yip S; Day BW; Verhaak RGW; Buckland M; Amanuel B; Simes J; De Lourenco RA; Solano NZ; Calder R; Adda L; Ahern E; Cooper A; Dowling A; Harrup R; Kichenadasse G; Lau B; Lynam J; Lwin Z; Wheeler H; Whittle JR; Norrie A; Harrison R; Mason WP; De Robles P; Maddula M; Gan HK, 2025, 'Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS (LUMOS2) study', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, pp. v423 - v424, http://dx.doi.org/10.1093/neuonc/noaf201.1676
Pitiyarachchi O; Sim H-W, 2024, 'PIK3CA mutations in pancreatic ductal adenocarcinoma (PDAC)', in ANNALS OF ONCOLOGY, ELSEVIER, SINGAPORE, Singapore, pp. S1499 - S1499, presented at European-Society-for-Medical-Oncology Asia Congress (ESMO), SINGAPORE, Singapore, 06 December 2024 - 08 December 2024, http://dx.doi.org/10.1016/j.annonc.2024.10.274
Mason SRE; Chung S; Satgunaseelan L; Mccool C; Juan BP-S; Gupta S; Zaman A; Day BW; Dear R; Sim H-W; Holst J; Chaffer CL, 2024, 'EXPLORING THE ROLE OF ANDROGEN RECEPTOR SIGNALING IN GLIOBLASTOMA IN AN ORTHOTOPIC ANIMAL MODEL', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, TX, Houston, presented at 29th Annual Meeting and Education Day of the Society-for-Neuro-Oncology (SNO), TX, Houston, 21 November 2024 - 24 November 2024, http://dx.doi.org/10.1093/neuonc/noae165.0957
Haggstrom L; Chan W; Nagrial A; Chantrill L; Yip D; Sim H-W; Chin V, 2024, 'Chemotherapy and Radiotherapy for Advanced Pancreatic Cancer: A Cochrane Systematic Review and Meta-Analysis', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 39 - 40
McNamee N; Lin F; Sim H-W; Napier C; Thomas D; Simes J; Thavaneswaran S, 2023, 'EXPLORING THE PROGNOSTIC IMPLICATIONS OF MOLECULAR ALTERATIONS IN ASTROCYTOMAS USING COMPREHENSIVE GENOMIC PROFILING (CGP)', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, CANADA, Vancouver, presented at 28th Annual Scientific Meeting of the Society-for-Neuro-Oncology (SNO), CANADA, Vancouver, 15 November 2023 - 19 November 2023
Mason S; Chung S; Juan BPS; Sim H-W; Dear R; Day B; Holst J; Chaffer C, 2023, 'TARGETING ANDROGEN SIGNALING IN GLIOBLASTOMA', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, CANADA, Vancouver, presented at 28th Annual Scientific Meeting of the Society-for-Neuro-Oncology (SNO), CANADA, Vancouver, 15 November 2023 - 19 November 2023
Sim HW; Wachsmuth L; Barnes EH; Yip S; Koh ES; Hall M; Jennens R; Ashley DM; Verhaak RG; Heimberger AB; Rosenthal MA; Hovey EJ; Ellingson BM; Tognela A; Gan HK; Wheeler H; Back M; Mcdonald KL; Long A; Cuff K; Begbie S; Gedye C; Mislang A; Le H; Johnson MO; Kong BY; Simes JR; Lwin Z; Khasraw M, 2023, 'NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma', in Neuro Oncology Advances, http://dx.doi.org/10.1093/noajnl/vdad124
Yuile A; Satgunaseelan L; Alexander KL; Thavaneswaran S; Krasovitsky M; Buckland M; Lee M; Wei G; Kastelan M; Wong M; Wilson I; Bayly A; Varikat W; Sim H-W; Kong B; Lwin Z; Turner C; Back M; Miller S; Lee A; Wheeler H, 2022, 'CLINICAL IMPACT OF CDKN2A/B DELETIONS IN IDH-MUTANT ASTROCYTOMAS', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, FL, Tampa, pp. 41 - 41, presented at 27th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO), FL, Tampa, 16 November 2022 - 20 November 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000888571000165&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Sim H-W; Lwin Z; Barnes E; McDonald K; Koh E-S; Rosenthal M; Foote M; Back M; Wheeler H; Buckland M; Walsh K; Fisher L; Leonard R; Hall M; Ashley D; Yip S; Simes J; Sulman E; Khasraw M, 2022, 'GENOME-WIDE DNA METHYLATION PATTERNS IN VERTU: A RANDOMIZED PHASE II TRIAL OF VELIPARIB, RADIOTHERAPY AND TEMOZOLOMIDE IN PATIENTS WITH MGMT-UNMETHYLATED GLIOBLASTOMA', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, FL, Tampa, pp. 81 - 81, presented at 27th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO), FL, Tampa, 16 November 2022 - 20 November 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000888571000310&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Kong B; Sim H-W; Koh E-S; Gan H; Barnes EH; Yip S; Nowak AK; Lau P; Cuff K; Khoo E; Lwin Z; Cooper A; Dowling A; Linton A; Harrup R; Dunlop T; Hovey E; Parkinson J; Jeffree R; Hall M; Tu E; Andrew D; Simes J; Gedye C, 2021, 'THE MULTI-ARM GLIOBLASTOMA AUSTRALASIA (MAGMA) TRIAL', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, MA, Boston, pp. 193 - 194, presented at 26th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO), MA, Boston, 18 November 2021 - 21 November 2021
Kong B; Sim H-W; Amanuel B; Day B; Buckland M; Verhaak R; Yip S; Johns T; Lwin Z; Rosenthal M; Nowak AK; Barnes EH; Scott AM; Parkinson J; Jeffree R; Lourenco RDA; Lau P; Whittle J; Hovey E; Cher L; Kichendasse G; Hall M; Robinson C; Thomas M; Giardina T; Tu E; Khasraw M; Koh E-S; Gan H, 2021, 'LOW AND INTERMEDIATE GRADE GLIOMA UMBRELLA STUDY OF MOLECULAR GUIDED THERAPIES (LUMOS) STUDY', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, MA, Boston, pp. 106 - 106, presented at 26th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO), MA, Boston, 18 November 2021 - 21 November 2021, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000757356200422&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Tuzesi A; Hallal S; Vafee F; Shivalingam B; Sim H-W; Buckland M; Alexander-Kaufman K, 2021, 'Plasma extracellular vesicles for brain tumours diagnostic and disease progression monitoring', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 58 - 59, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693805000110&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Hallal S; Tuzesi A; Wei H; Lee M; Sim H-W; Shivalingam B; Buckland M; Alexander (Kaufman) K, 2021, 'SWATH-MS protein profiling of plasma extracellular vesicles determines markers for GBM progression', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 58 - 58, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693805000109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Zeuge U; Zhan L; Bucur R; Sauerzopf K; Aggarwal R; Feng S; Sim H-W; Cheng D; Zhang W-J; Moulton C-A; Mcgilvray I; Cleary S; Gallinger S; Sapisochin G; Knox J; Wei A; Liu G; Chen E, 2021, 'Preoperative artemin as predictive biomarker for survival in curatively resected hepatocellular carcinoma', in JOURNAL OF HEPATOLOGY, ELSEVIER, pp. S508 - S508, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000667753801039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Ardolino L; Joshua A; Horvath L; Mahon K; Mak B; Fizazi K; Sommer GS; Carles J; Sim H-W, 2021, 'The influence of concurrent lipid modifying medications in men receiving docetaxel or cabazitaxel for mCRPC - A meta-analysis of the FIRSTANA, PROSELICA, TAX-327 and TROPIC studies', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 68 - 69
Ma LX; Sun P; Espin-Garcia O; Suzuki C; Jiang DM; Lim CH; Taylor K; Chan BA; Sim H-W; Natori A; Chen EX; Liu G; Knox JJ; Yeung J; Darling GE; Kim J; Kalimuthu S; Elimova E; Jang RW-J, 2020, 'Patterns of disease, treatment, and outcomes of esophageal cancer arising within a previous radiation treatment field', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology, CA, San Francisco, 23 January 2020 - 25 January 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530922700312&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Feng S; Sim H-W; Bucur R; Aggarwal R; Abreu P; Ray M; Herman M; Cheng D; Chen Z; Zhang W; Greig PD; Wei AC-C; Moulton C-A; McGilvray IM; Cleary SP; Gallinger S; Sapisochin G; Knox JJ; Liu G; Chen EX, 2020, 'Preoperative serum artemin (ARTN) as a predictive biomarker of recurrence following curative resection for hepatocellular carcinoma (HCC)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology, CA, San Francisco, 23 January 2020 - 25 January 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530922700550&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Hecht JR; Lonardi S; Bendell JC; Sim H-W; Macarulla T; Lopez CD; Van Cutsem E; Martin AJM; Park JO; Greil R; Lin Y; Rao S; Ryoo B-Y, 2020, 'Randomized Phase III Study of FOLFOX Alone and with Pegilodecakin as Second-line Therapy in Patients with Metastatic Pancreatic Cancer (SEQUOIA)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology, CA, San Francisco, 23 January 2020 - 25 January 2020
Haider S; Dai E; Sim H; Balakrishnar B; Descallar J; Ding P; Chua W, 2020, 'Systematic review and meta-analysis of treatment related toxicities from second-generation androgen receptor inhibitors in advanced prostate cancer', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 121 - 121
Sim H-W; Barnes E; Lwin Z; Rosenthal M; Wheeler H; Koh E-S; Foote MC; Fisher L; Leonard R; Hall M; Simes J; Khasraw M, 2019, 'Health-related quality of life (HRQL) in VERTU: A randomized phase II trial of veliparib (V), radiotherapy (RT), and temozolomide (TMZ) for newly diagnosed MGMT unmethylated (uMGMT) glioblastoma (GBM).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 55th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2019 - 04 June 2019, http://dx.doi.org/10.1200/JCO.2019.37.15_suppl.2042
Nejad R; Nassiri F; Mamatjan Y; Sim H-W; Chen E; Agnihotri S; Aldape K; Zadeh G, 2018, 'LOWER GRADE ISOCITRATE DEHYDROGENASE (IDH) MUTANT GLIOMAS METABOLICALLY MIMICKING GLIOBLASTOMA (GBM) EXPRESS HIGHER R:S 2-HYDROXYGLUTARATE RATIOS RELATIVE TO NON-GBM-MIMICKING IDH MUTANT GLIOMAS', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, LA, New Orleans, pp. 33 - 33, presented at 23rd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd CNS Anticancer Drug Discovery and Development Conference, LA, New Orleans, 14 November 2018 - 18 November 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000460646300127&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Xu K; Lo A; Chin V; Gzell C; O'Connor C; Forstner D; Gallagher R; Bova R; Crawford J; Harvey R; Lochhead A; Earls P; Qiu MR; Hsu E; Bigg-Wither G; Chan L; Bao H; Foltyn P; Sim HW; Prawira A, 2018, 'Development of overall survival (OS) and progression free survival (PFS) nomograms for Australian patients with locoregionally advanced oropharyngeal squamous cell carcinoma (LA OPSCC)', in Annals of oncology : official journal of the European Society for Medical Oncology, pp. viii389, http://dx.doi.org/10.1093/annonc/mdy287.049
Back to profile page
https://orcid.org/0000-0002-2530-0523